JOURNAL of
ONCOLOGICAL
SCIENCES

Similar Articles


  • Epidemiology of Lung Cancer in Women: A Hospital-Based Descriptive Study aAcıbadem Mehmet Ali Aydınlar University Faculty of Medicine, Department of Medical Oncology, İstanbul, TURKEY bAcıbadem Mehmet Ali Aydınlar University Faculty of Medicine, 5th Year Medical Student, İstanbul, TURKEY cİstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, 5th Year Medical Student, İstanbul, TURKEY DOI: 10.37047/jos.2020-73409 Sayfalar: 29 - 34 1534 Viewed.



  • Coexistence of Atrial Myxoma and Gastrointestinal Stromal Tumor aAkdeniz University Faculty of Medicine, Department of Medical Oncology, Antalya, TURKEY bAkdeniz University Faculty of Medicine, Department of Pathology, Antalya, TURKEY DOI: 10.37047/jos.2019-71885 Sayfalar: 119 - 122 2078 Viewed.

  • The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients aMuğla Sıtkı Koçman University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Muğla, TURKEY bAnkara University Faculty of Medicine, Department of Internal Medicine, Division of Geriatrics, Ankara, TURKEY cAnkara University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Ankara TURKEY dAnkara University Faculty of Medicine, Department of Internal Medicine, Ankara TURKEY DOI: 10.37047/jos.2019-71889 Sayfalar: 65 - 70 2230 Viewed.


  • Stem Cells and Psyche: Perspectives and a Review of the Literature aAnkara University Faculty of Medicine, Department of Psychiatry, Division of Consultation-Liaison Psychiatry, Ankara, TURKEY bAnkara University Faculty of Medicine, Department of Hematology, Ankara, TURKEY cAnkara University Stem Cell Institute, Ankara, TURKEY dAnkara University Faculty of Medicine, Department of Child and Adolescent Psychiatry, Ankara, TURKEY DOI: 10.37047/jos.2019-71899 Sayfalar: 103 - 118 1975 Viewed.

  • Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study aBaşkent University Faculty of Medicine, Division of Gynecologic Oncology, Ankara, TURKEY bTrakya University Faculty of Medicine, Department of Medical Oncology, Edirne, TURKEY cUniversity of Health Sciences, Zekai Tahir Burak Women’s Health Training and Research Hospital, Department of Gynecologic Oncology, Ankara, TURKEY dUniversity of Health Sciences, Etlik Zübeyde Hanim Women’s Health Training and Research Hospital, Department of Gynecologic Oncology, Ankara, TURKEY eAnkara University Faculty of Medicine, Division of Gynecologic Oncology, Ankara, TURKEY fUniversity of Health Sciences Tepecik Education and Research Hospital, Department of Gynecologic Oncology, İzmir, TURKEY gUniversity of Health Sciences Kanuni Sultan Süleyman Training and Research Hospital, Department of Gynecologic Oncology, İstanbul, TURKEY hİstanbul University İstanbul Faculty of Medicine, Department of Medical Oncology, İstanbul, TURKEY iIstanbul University İstanbul Faculty of Medicine, Division of Gynecologic Oncology, İstanbul, TURKEY DOI: 10.37047/jos.2019-73073 Sayfalar: 78 - 86 1984 Viewed.

  • Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study aTrakya University Faculty of Medicine, Department of Internal Medicine, Division of Oncology, Edirne, TURKEY bGazi University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Ankara, TURKEY cHacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Ankara, TURKEY dDr. Abdurrahman Yurtarslan Ankara Oncology Training and Research Hospital, Department of Internal Medicine, Division of Medical Oncology, Ankara, TURKEY eUniversiy of Health Sciences Ankara Numune Training and Research Hospital, Clinic of Medical Oncology, Ankara, TURKEY fNecmettin Erbakan University Meram Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Konya, TURKEY gGaziantep University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Gaziantep, TURKEY hDicle University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Diyarbakır, TURKEY iMarmara University Pendik Training and Research Hospital, Department of Internal Medicine, Division of Medical Oncology, İstanbul, TURKEY jKartal Dr. Lütfi Kirdar Training and Research Hospital, Department of Medical Oncology, İstanbul, TURKEY kBezmialem Vakıf University Faculty of Medicine, Department of Medical Oncology, İstanbul, TURKEY lİnönü University Turgut Ozal Medical Center, Department of Internal Medicine, Division of Medical Oncology, Malatya, TURKEY mAli Osman Sönmez Oncology Hospital, Department of Medical Oncology, Bursa, TURKEY nIstanbul University Istanbul Medical Faculty, Department of Medical Oncology, İstanbul, TURKEY oKaradeniz Technical University Faculty of Medicine, Department of Internal Medicine, Trabzon, TURKEY pDokuz Eylül University Faculty of Medicine, Department of Medical Oncology, İzmir, TURKEY rIzmir Katip Çelebi University Atatürk Training and Research Hospital, Department of Medical Oncology, İzmir, TURKEY sPfizer Pharmaceuticals, Medical Oncology Department, İstanbul, TURKEY tErciyes University Faculty of Medicine, Department of Internal Medicine, Kayseri, TURKEY DOI: 10.37047/jos.2020-75080 Sayfalar: 87 - 95 2232 Viewed.




  • Expression of Caspase-9 in Early and Locally Advanced Stage Squamous Cell Lung Cancer aDepartment of Medical Oncology, Pamukkale University Faculty of Medicine, Denizli, TURKEY bDepartment of Medical Biology, Pamukkale University Faculty of Medicine, Denizli, TURKEY cClinic of Medical Oncology, Kayseri City Hospital, Kayseri, TURKEY dClinic of Medical Oncology, Van Training and Research Hospital, Van, TURKEY eDepartment of Pathology, Pamukkale University Faculty of Medicine, Denizli, TURKEY fDepartment of Social Pediatrics, Pamukkale University Faculty of Medicine, Denizli, TURKEY DOI: 10.37047/jos.2020-76948 Sayfalar: 147 - 152 2247 Viewed.